scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Heer H Mehta | Q90065580 |
Yousif Shamoo | Q47142624 | ||
P2860 | cites work | Challenges in the diagnosis and management of Nocardia infections in lung transplant recipients | Q82107548 |
Nocardia spp infections among hematological patients: results of a retrospective multicenter study | Q86247585 | ||
Pulmonary nocardiosis masquerading renascence of tuberculosis in an immunocompetent host: a case report from Nepal | Q90285597 | ||
Pulmonary nocardiosis in Western Europe-Clinical evaluation of 43 patients and population-based estimates of hospitalization rates | Q91112412 | ||
Antimicrobial‐ResistantNocardiaIsolates, United States, 1995–2004 | Q42831386 | ||
Nocardia cyriacigeorgica--an established rather than an emerging pathogen | Q42942725 | ||
Nocardiosis in Quebec, Canada, 1988-2008. | Q43811367 | ||
The Complexities of Nocardia Taxonomy and Identification | Q46265503 | ||
Using experimental evolution to identify druggable targets that could inhibit the evolution of antimicrobial resistance | Q47775468 | ||
Pathogenic Nocardia cyriacigeorgica and Nocardia nova evolve to resist trimethoprim-sulfamethoxazole by both expected and unexpected pathways. | Q52568631 | ||
Clinical assessment of a Nocardia spp. polymerase chain reaction (PCR)-based assay for the diagnosis of nocardiosis. | Q54094433 | ||
Effects of human neutrophils and monocytes on Nocardia asteroides: failure of killing despite occurrence of the oxidative metabolic burst. | Q54548742 | ||
Manifestations and outcomes of nocardia infections: Comparison of immunocompromised and nonimmunocompromised adult patients | Q57059504 | ||
Clinical and microbiological features of nocardiosis 1997-2003 | Q64135445 | ||
Evaluating the Contribution of Nocardia spp. and Mycobacterium tuberculosis to Pulmonary Infections among HIV and Non-HIV Patients at the Komfo Anokye Teaching Hospital, Ghana. | Q64928950 | ||
Nocardial infections in the United States, 1972-1974 | Q67494245 | ||
A toxic substance produced by Nocardia otitidiscaviarum isolated from cutaneous nocardiosis | Q68688443 | ||
Induction of L-phase variants of Nocardia caviae within intact murine lungs | Q24556585 | ||
Biochemical and structural characterization of the putative dihydropteroate synthase ortholog Rv1207 of Mycobacterium tuberculosis | Q27651420 | ||
Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE | Q28276828 | ||
Molecular identification of nocardia isolates from clinical samples and an overview of human nocardiosis in Brazil | Q28536111 | ||
Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy | Q31036653 | ||
Nocardiosis at the turn of the century | Q33480902 | ||
Integrons: past, present, and future. | Q33743517 | ||
Isolation, biochemical and molecular identification of Nocardia species among TB suspects in northeastern, Tanzania; a forgotten or neglected threat? | Q33776974 | ||
Interaction of Nocardia asteroides with rabbit alveolar macrophages: association of virulence, viability, ultrastructural damage, and phagosome-lysosome fusion. | Q33903261 | ||
Resistance to trimethoprim-sulfamethoxazole | Q33945728 | ||
Nocardia infection in chronic granulomatous disease | Q34141669 | ||
Nocardiosis: updates and clinical overview | Q34265302 | ||
The Nocardia cyriacigeorgica GUH-2 genome shows ongoing adaptation of an environmental Actinobacteria to a pathogen's lifestyle | Q34691001 | ||
Nocardiosis in cancer patients | Q34917542 | ||
Nocardia co-infection in patients with pulmonary tuberculosis. | Q35104955 | ||
Genetic basis for in vivo daptomycin resistance in enterococci | Q35499202 | ||
The molecular basis of antifolate resistance in Plasmodium falciparum: looking beyond point mutations | Q35513977 | ||
Resistance gene pool to co-trimoxazole in non-susceptible Nocardia strains | Q35545608 | ||
Nocardiosis: review of clinical and laboratory experience | Q35553558 | ||
Delayed commitment to evolutionary fate in antibiotic resistance fitness landscapes | Q35994748 | ||
Analysis of the complete genome sequence of Nocardia seriolae UTF1, the causative agent of fish nocardiosis: The first reference genome sequence of the fish pathogenic Nocardia species | Q36296764 | ||
Nocardia species: host-parasite relationships | Q36641326 | ||
The medically important aerobic actinomycetes: epidemiology and microbiology | Q36641751 | ||
Role of superoxide dismutase and catalase as determinants of pathogenicity of Nocardia asteroides: importance in resistance to microbicidal activities of human polymorphonuclear neutrophils | Q37039916 | ||
Intracellular acid phosphatase content and ability of different macrophage populations to kill Nocardia asteroides | Q37074878 | ||
Not everything acid fast is Mycobacterium tuberculosis--a case report | Q37224827 | ||
Adaptation of Enterococcus faecalis to daptomycin reveals an ordered progression to resistance | Q37263496 | ||
Susceptibility profiles of Nocardia spp. to antimicrobial and antituberculotic agents detected by a microplate Alamar Blue assay. | Q37677075 | ||
Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study | Q40709377 | ||
Nocardiosis | Q41092216 | ||
Nocardiosis in 132 patients with cancer: microbiological and clinical analyses | Q41732618 | ||
Susceptibility of 186 Nocardia sp. isolates to 20 antimicrobial agents | Q42015418 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P921 | main subject | emerging pathogen | Q108429945 |
P304 | page(s) | e1008280 | |
P577 | publication date | 2020-03-05 | |
P1433 | published in | PLOS Pathogens | Q283209 |
P1476 | title | Pathogenic Nocardia: A diverse genus of emerging pathogens or just poorly recognized? | |
P478 | volume | 16 |
Q110696385 | Genome insights into the pharmaceutical and plant growth promoting features of the novel species Nocardia alni sp. nov | cites work | P2860 |
Search more.